1. 跳轉至内容
  2. 跳轉至主選單
  3. 跳轉到更多DW網站

中國指控英藥品公司經濟犯罪

2013年7月11日
https://p.dw.com/p/196RP
epa03293139 An undated handout photo from drug maker GlaxoSmithKline PLC shows the company's corporate offices in Brentford, Middlesex, Britain. GSK has reportedly has been hit with a USD 3 billion fine by the US Justice Department and will plead guilty to misbranding drugs Paxil and Welbutrin into interstate commerce. According to the government the drugs were marketed for afflictions for which they had not been approved. The fine is the larges payment by a US drug manufacturer and the largest fraud settlement in US history. EPA/GLAXOSMITHKLINE HANDOUT EDITORIAL USE ONLY NO SALES
GalxoSmithKline PLC Pharmakonzern Brentford Middlesex Britannien圖片來源: picture-alliance/dpa

據法新社報導,中國公安部周四通報稱,英國藥品公司葛蘭素史克(GSK)公司部分高管涉嫌商業賄賂和涉稅犯罪等「嚴重經濟犯罪行為」。公安部的相關聲明中寫道,作為一個大型的跨國藥品公司,葛蘭素史克(中國)公司近年來對一些政府官員、大批醫藥行業協會和基金會以及醫院、醫生進行了大肆行賄,以達到擴大藥品銷路、提高售價的目的。此外,公安部還援引上海、長沙和鄭州等地警方調查訊息稱,該公司還涉嫌涉稅犯罪。據悉,該公司一些高管已經對犯罪行為供認不諱。公安部的聲明未透露涉案人員的國籍,但倫敦外交部門稱正在為一名英國籍人士提供領事援助。